Healthcare, Pharma & Chemicals
The healthcare industry comprises many segments and ranges from inpatient clinics and facilities (acute care, rehabilitation, nursing care), outpatient care (including practice chains, medical care centres, intensive care), research, production and sales in the pharmaceutical, medical technology and biotechnology sectors, contract manufacturing and services (such as diagnostics or consulting) to trading in these products.
All segments of the healthcare industry are characterised by dynamic growth, primarily due to the ageing population and medical advances. The healthcare sector has been at the forefront of M&A transactions in Germany and Europe for years. Innovative companies are regularly founded in the healthcare sector, which is reflected in the very high number of patents, among other things. The majority of these companies is absorbed into larger market players with the help of M&A.
Looking at the chemical industry in Germany, it is characterised by cost pressure in Germany as a high-wage location. The production of basic chemicals has been relocated to Asia for decades. Nevertheless, the medium-sized chemical industry is holding its own in Germany, be it in the areas of plastic additives, paints and coatings or contract manufacturing. Market consolidation in the sector is being fuelled in particular by rising energy and personnel costs and thus falling margins.
Dr. Wolfgang Wybranietz
Head of Corporate Finance M&A Frankfurt
Wolfgang Wybranietz joined the former DZ BANK M&A team in 2001 and has been part of the Frankfurt team of the Corporate Finance / M&A department ever since.
Since 2019, he has been Head of the Frankfurt M&A team. Wolfgang is responsible for the healthcare (pharma, biotech, medtech, clinics, nursing homes), chemicals and agriculture sectors and has successfully advised a large number of clients over the past 20 years.
Before joining DZ BANK, Wolfgang Wybranietz worked in basic medical research and spent 6 years working on virus vectors in the treatment of liver cancer.
Wolfgang Wybranietz received his diploma in biochemistry from the University of Tübingen and subsequently completed his doctorate at the Medical University Hospital in Tübingen. As part of his studies, he spent a year in San Francisco and Berkeley and during his doctoral thesis at the Marie Curie Institute in England.
Despite his advanced age, Wolfgang Wybranietz regularly enjoys squash in his private life and rarely avoids political discussions.
Dr. Georgi Bontschev
Managing Director M&A
Georgi Bontschev has been part of the Frankfurt team in the Corporate Finance / M&A department since 2011. Before joining the firm, he worked for a medium-sized consultancy specialising in M&A and restructuring. He can look back on a large number of successfully completed, often cross-border transactions in various industries. He has proven sector and transaction experience in the healthcare and industrial sectors with a focus on electronics.
Georgi Bontschev studied business administration at the Universities of Mannheim and St. Gallen. He completed his doctorate at the European Business School (ebs) in Oestrich-Winkel with a stop at the University of Michigan, Ann Arbor.
He spends his free time with his family, outdoors and doing sport.
